Estrogen exerts protective effects in HCC through its receptors, mainly estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ), which are associated with better overall survival and disease-free survival in patients (Figure 1). This evidence concerns the gene ESR2 and hepatocellular carcinoma.